Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: Results of a factorial randomised trial

British Journal of Cancer

Volumn 105, Issue 4, 2011, Pages 475-480

  Hewitson, P ^a   Ward, A M ^a   Heneghan, C ^a   Halloran, S P ^b   Mant, D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

cancer screening; Colorectal cancer; patient information; primary care

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HUMAN; INFORMATION DISSEMINATION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PATIENT INFORMATION; PATIENT PARTICIPATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; COLORECTAL NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORRESPONDENCE AS TOPIC; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PAMPHLETS; PERSUASIVE COMMUNICATION; PRIMARY HEALTH CARE; REAGENT KITS, DIAGNOSTIC; RESEARCH DESIGN;

EID: 80051593819     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.255     Document Type: Article

References (31)

1. Bandura A (2004) Health promotion by social cognitive means. Health Educ Behav 31: 143-164 (Pubitemid 38569365)
2. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M, EUROCARE Working Group (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8: 773-783 (Pubitemid 47321600)
3. Brawarsky P, Brooks DR, Mucci LA, Wood PA (2004) Effect of physician recommendation and patient adherence on rates of colorectal cancer testing. Cancer Detect Prevent 28: 260-268 (Pubitemid 40125376)
4. Cancer Research UK. Bowel (colorectal) cancer-UK mortality statistics. http://info.cancerresearchuk.org/cancerstats/types/bowel/mortality/
5. Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP (2007) An advance notification letter increases participation in colorectal cancer screening. J Med Screen 14: 73-75 (Pubitemid 47067760)
6. Cole SR, Young GP, Byrne D, Guy JR, Morcom J (2002) Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen 9: 147-152 (Pubitemid 36135339)
7. Denis B, Ruetsch M, Strentz P, Vogel JY, Guth F, Boyaval JM, Pagnon X, Ebelin JF, Gendre I, Perrin P (2007) Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 56: 1579-1584 (Pubitemid 350033197)
8. Dolan NC, Ferreia MR, Davis TC, Fitzgibbon ML, Rademaker A, Liu D, Schmitt BP, Gorby N, Wolf M, Bennett CL (2004) Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol 22: 2617-2622 (Pubitemid 41103749)
9. Green S, Liu P, O'Sullivan J (2002) Factorial design considerations. J Clin Oncol 20: 3423-3430
10. Gurusamy KS, Gluud C, Nikolova D, Davidson BR (2011) Design of surgical randomized controlled trials involving multiple interventions. J Surg Res 165: 118-127
11. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E (2007) Screening for colorectal cancer using the faecal occult blood test: an update. Cochrane Database Syst Rev (1): CD001216
12. Ling BS, Schoen RE, Trauth JM, Wahed AS, Eury T, Simak D, Solano FX, Weissfeld JL (2009) Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med 169: 47-55
13. McAlister FA, Straus SE, Sackett DL, Altman DL (2003) Analysis and reporting of factorial trials: a systematic review. JAMA 289: 2545-2553 (Pubitemid 37430156)
14. Miller DP, Kimberly JR, Case LD, Wofford JL (2005) Using a computer to teach patients about fecal occult blood screening: a randomized trial. J Gen Intern Med 20: 984-988 (Pubitemid 41726650)
15. Montgomery AA, Peters TJ, Little P (2003) Design, analysis and presentation of factorial randomised controlled trials. BMC Med Res Methodol 3: 26
16. National Cancer Intelligence Network (2009) Colorectal cancer survival by stage. http://library.ncin.org.uk/docs/090623-NCIN-colorectal-survival- databriefing.pdf
17. Parkin DM, Tappenden P, Olsen AH, Patnick J, Sasieni P (2008) Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen 15: 163-174
18. Peterson NB, Dwyer KA, Mulvaney SA, Dietrich MS, Rothman RL (2007) The influence of health literacy on colorectal cancer screening knowledge, beliefs and behavior. J Nat Med Assoc 99: 1105-1112 (Pubitemid 47614581)
19. Rothman AJ, Bartels RD, Wlaschin J, Salovey P (2006) The strategic use of gain-and loss-framed messages to promote health behavior: how theory can inform practice. J Comm 56: 202-220
20. Rothman AJ, Kiviniemi MT (1999) Treating people with information: an analysis of review of approaches to communication health risk information. J Natl Cancer Int Monogr 25: 44-51
21. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ (2004) Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 100: 2093-2103 (Pubitemid 38580326)
22. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Zappa M, SCORE2 Working Group (2005) Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Int Monogr 97: 347-357 (Pubitemid 40425953)
23. Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L, Castiglinoe G, Grazzini G, Taddei S, Gasperoni S, Giuliani O, Malfitana G, Marutti A, Genta G, Segnan N (2010) Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation. Am J Gastroenterol 105: 188-198
24. Subramanian S, Klosterman M, Amonkar MM, Hunt TL (2004) Adherence with colorectal cancer screening guidelines: a review. Prev Med 38: 536-550 (Pubitemid 38452879)
25. Steele RJC, Kostourou I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser C (2010) Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening. BMJ 341: c5531
26. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ (2005) Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med 20: 278-282 (Pubitemid 40628733)
27. von Wagner C, Good A, Wright D, Rachet B, Obichere A, Bloom S, Wardle J (2009) Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. Br J Cancer 101: S60-S63
28. Weller D, Moss S, Butler P, Campbell C, Coleman D, Melia J, Robertson R (2006) English Pilot of Bowel Cancer Screening: an evaluation of the second round. http://www.cancerscreening.nhs.uk/bowel/pilot-2nd-round-evaluation.pdf
29. Woodrow C, Watson E, Rozmovits L, Parker R, Austoker J (2008) Public perceptions of communicating information about bowel cancer screening. Health Expect 11: 16-25 (Pubitemid 351239421)
30. Zajac IT, Whibley AH, Cole SR, Byrne D, Guy J, Morcom J, Young GP (2010) Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis. J Med Screen 17: 19-24
31. Zhang J, Kai FY (1998) What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280: 1690-1691 (Pubitemid 28532993)